ResearchMoz

GBI Research Market Research Reports

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

List of reports from GBI Research

Displaying 1 to 30 (of 629 records)
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
Jul 2014  
GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an...
$3500
Market Snapshot: Transcatheter Heart Valves 2007 to 2020 - Americas
Jul 2014  
GBI Research’s report: “Transcatheter Heart Valves 2007 to 2020 – Americas” provides quantitative analysis of the transcatheter heart valves market in Americas. The analysis includes market size data by revenue and volume over the 2007–2020 period and key company share data by revenue in 2013 for the following countries: US, Canada, Brazil and Mexico. It uses...
$1750
Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)
Jul 2014  
GBI Research’s report, “Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the...
$1750
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 - Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)
Jun 2014  
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 Benelux and Scandinavia (Netherlands, Belgium, Luxembourg, Sweden, Denmark and Norway)” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key...
$1750
Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific
Jun 2014  
Mammography Systems 2006 to 2020 – Asia-Pacific provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and...
$1750
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
Jun 2014  
GBI Research, a leading business intelligence provider, has released its latest research report: “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany”. Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the...
$3500
Market Snapshot: Glucose Monitoring Devices 2014 - Benelux and Scandinavia
Jun 2014  
GBI Research’s report: “Glucose Monitoring Devices 2014 – Benelux and Scandinavia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in...
$3500
Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
Jun 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries ’, which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five...
$3500
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
Jun 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs ’, which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top...
$3500
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation
May 2014  
Psoriasis is a chronic, inflammatory disease triggered by deregulated Thymus-derived (T) cells, resulting inflammation and benign hyperplasia of keratinocytes within the skin. Manifestations of affected skin are red, thickened plaques with an overlying silver-white scale, which significantly impairs the patient’s physical and mental wellbeing. The primary cause of psoriasis is unknown,...
$3500
Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia
May 2014  
GBI Research’s report: "Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for...
$1750
Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets
May 2014  
GBI Research’s report: “Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets” discusses the market, competitive landscape, and trends for two facial aesthetics market segments: Botox and dermal fillers. It provides comprehensive information on the key trends affecting these segments, and...
$3500
Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies
May 2014  
“Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free Survival and Targeted Therapies”. The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease (both first-line and recurrent). Initial...
$3500
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options
May 2014  
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 – Novel HER-2 Positive Therapies Provide Diversified Treatment Options’, which provides in-depth analysis of breast cancer market within the Asia-Pacific (APAC) covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2013, along with market forecast until 2020....
$3500
HIV Therapeutics in Major Developed Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
Apr 2014  
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market...
$3500
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
Apr 2014  
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the...
$3500
HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
Apr 2014  
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market...
$3500
Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
Apr 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets...
$3500
Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
Apr 2014  
GBI Research’s report: Insulin Delivery Devices Market to 2019 examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market...
$3500
Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns
Mar 2014  
GBI Research has released its pharma research: ‘Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns ’, which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation...
$3500
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
Mar 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘NSCLC Therapeutics in APAC Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool’, which provides in-depth insights into the Non-Small Cell Lung Cancer (NSCLC) indication. The report provides an estimation of the market...
$3500
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
Mar 2014  
GBI Research, the leading business intelligence provider, has released its latest research: ‘Epilepsy Therapeutics to 2019 in Asia-Pacific Market’, which provides in-depth analysis of epilepsy market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market...
$3500
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth
Feb 2014  
GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth.” The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in...
$3500
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description
Feb 2014  
GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be...
$3500
Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers
Feb 2014  
GBI Research’s report: “Glucose Monitoring Device Market to 2019 - Technology adoption and increasing health awareness serve as distinct regional growth drivers” looks at the market, competitive landscape, and trends for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. The report provides comprehensive...
$3500
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape
Jan 2014  
GBI Research, has released the pharma report – “Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape”. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1...
$3500
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need
Jan 2014  
GBI Research, the leading business intelligence provider, has released its latest research, "Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need", which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and...
$3500
Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries
Jan 2014  
GBI Research, the leading business intelligence provider, has released its latest research, ‘Gastrointestinal Therapeutics (Irritable Bowel Syndrome, Ulcerative Colitis and Crohn’s Disease) in Major Developed Markets’, which provides insights into three gastrointestinal therapeutic indications in the major developed markets of the US, the UK, France, Germany, Italy,...
$3500
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
Dec 2013  
The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, targeted therapies. Whilst the only Food and Drug Administration (FDA)-approved biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab),...
$3500
Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth
Dec 2013  
GBI Research has released the pharma report - “Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth” Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract. They are often diagnosed at advanced, incurable stages due to a late onset of symptoms,...
$3500
 
Displaying 1 to 30 (of 629 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData